SCHEMBL7950643

SCHEMBL7950643

Cc1ccc2c(c1)NC(=O)C(NC(=O)OC(C)(C)C)CN2C(=O)CC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.38
EPHX2 P34913 1/20 0.37
USP2 O75604 2/20 0.34
HSD17B10 Q99714 2/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
TSHR P16473 1/20 0.33
IDO1 P14902 1/20 0.33
NAAA Q02083 1/20 0.33
PIM1 P11309 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7950687 0.88 GAA (0.40) GAAEPHX2USP2HSD17B10KDM4E
SCHEMBL6176303 0.87 GAA (0.40) GAAEPHX2USP2HSD17B10HDAC2
SCHEMBL6179125 0.86 EPHX2 (0.39) GAAEPHX2USP2HSD17B10KDM4E
SCHEMBL7959212 0.85 CCKBR (0.34) EPHX2MAPTTSHRCYP3A4
SCHEMBL6177881 0.85 GAA (0.38) GAAEPHX2USP2HSD17B10KDM4E
SCHEMBL7950813 0.84 GAA (0.37) GAAEPHX2USP2HSD17B10HDAC2
SCHEMBL6176414 0.84 EPHX2 (0.41) GAAEPHX2MEN1ALDH1A1KMT2A
SCHEMBL7960759 0.84 GAA (0.37) GAAEPHX2USP2HSD17B10KDM4E
SCHEMBL7959365 0.82 NPC1 (0.43) GAAEPHX2KMT2ANAAA
SCHEMBL7950898 0.81 HTT (0.43) GAAEPHX2HSD17B10KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed